![Editors in Conversation artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/b8/68/dd/b868dd9f-5a51-91c9-fb51-f8d1567e8465/mza_5151066038574592298.jpg/100x100bb.jpg)
Developing Non-Traditional Antibiotics (AAC ed.)
Editors in Conversation
English - March 19, 2021 13:00 - 40 minutes - 27.9 MB - ★★★★ - 10 ratingsLife Sciences Science Health & Fitness Medicine asm for fox interviews jeff magazine microbe microbiology news science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Fermentative Food Microbiome
Next Episode: Pandemic Built Environment (mSystems ed.)
Developing non-traditional antibiotics promises novel strategies to combat multidrug-resistant organisms but would they work? Are they feasible to develop?
Topics discussed:
• The notion of non-traditional antibiotics as potential therapeutics against MDR organisms
• Increasing our understanding on the clinical efficacy of non-traditional antibiotics
• Regulatory pathways for approval of such compounds
Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Editor-in-Chief, AMR.solutions
Visit https://aac.asm.org to browse issues and/or submit a manuscript.